These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19536472)

  • 21. Anti-inflammatory and utero-relaxant effects in human myometrium of new generation phosphodiesterase 4 inhibitors.
    Oger S; Méhats C; Barnette MS; Ferré F; Cabrol D; Leroy MJ
    Biol Reprod; 2004 Feb; 70(2):458-64. PubMed ID: 14561639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pregnancy induces a modulation of the cAMP phosphodiesterase 4-conformers ratio in human myometrium: consequences for the utero-relaxant effect of PDE4-selective inhibitors.
    Méhats C; Tanguy G; Paris B; Robert B; Pernin N; Ferré F; Leroy MJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):817-23. PubMed ID: 10640323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition.
    Abusnina A; Keravis T; Zhou Q; Justiniano H; Lobstein A; Lugnier C
    Thromb Haemost; 2015 Feb; 113(2):319-28. PubMed ID: 25230992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphodiesterase-4 inhibition improves corticosteroid insensitivity in pulmonary endothelial cells under oxidative stress.
    Ortiz JL; Milara J; Lluch J; De Diego A; Sanz C; Cortijo J
    Allergy; 2013 Jan; 68(1):64-73. PubMed ID: 23121078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating the magnitude of near-membrane PDE4 activity in living cells.
    Xin W; Feinstein WP; Britain AL; Ochoa CD; Zhu B; Richter W; Leavesley SJ; Rich TC
    Am J Physiol Cell Physiol; 2015 Sep; 309(6):C415-24. PubMed ID: 26201952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterus-relaxing effect of β2-agonists in combination with phosphodiesterase inhibitors: studies on pregnant rat in vivo and on pregnant human myometrium in vitro.
    Verli J; Klukovits A; Kormányos Z; Hajagos-Tóth J; Ducza E; Seres AB; Falkay G; Gáspár R
    J Obstet Gynaecol Res; 2013 Jan; 39(1):31-9. PubMed ID: 22765375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).
    Bivalacqua TJ; Champion HC; Rajasekaran M; Sikka SC; Kadowitz PJ; Doherty PC; Hellstrom WJ
    J Urol; 1999 Nov; 162(5):1848-55. PubMed ID: 10524946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of phosphodiesterase 4 enhances clitoral and vaginal blood flow responses to dorsal clitoral nerve stimulation or PGE1 in anesthetized female rats.
    Castiglione F; Bergamini A; Russo A; La Croce G; Castagna G; Colciago G; Salonia A; Rigatti P; Montorsi F; Hedlund P
    J Sex Med; 2013 Apr; 10(4):939-50. PubMed ID: 23347325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
    Barnette MS; Manning CD; Price WJ; Barone FC
    J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of increased cAMP content on inflammation, oxidative stress and PDE4 transcripts during Brucella melitensis infection.
    Erdogan S; Aslantas O; Celik S; Atik E
    Res Vet Sci; 2008 Feb; 84(1):18-25. PubMed ID: 17397885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors.
    Verghese MW; McConnell RT; Strickland AB; Gooding RC; Stimpson SA; Yarnall DP; Taylor JD; Furdon PJ
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1313-20. PubMed ID: 7891349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of cyclic AMP phosphodiesterase (PDE4) reverses memory deficits associated with NMDA receptor antagonism.
    Zhang HT; Crissman AM; Dorairaj NR; Chandler LJ; O'Donnell JM
    Neuropsychopharmacology; 2000 Aug; 23(2):198-204. PubMed ID: 10882846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of oxygen on phosphodiesterases (PDE) 3 and 4 isoforms and PKA activity in the superior cervical ganglia.
    Nunes AR; Sample V; Xiang YK; Monteiro EC; Gauda E; Zhang J
    Adv Exp Med Biol; 2012; 758():287-94. PubMed ID: 23080174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of a potent and biologically-active PDE4/7 inhibitor via fission yeast-based assays.
    de Medeiros AS; Wyman AR; Alaamery MA; Allain C; Ivey FD; Wang L; Le H; Morken JP; Habara A; Le C; Cui S; Lerner A; Hoffman CS
    Cell Signal; 2017 Dec; 40():73-80. PubMed ID: 28867658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological and molecular dynamics analyses of differences in inhibitor binding to human and nematode PDE4: Implications for management of parasitic nematodes.
    Schuster KD; Mohammadi M; Cahill KB; Matte SL; Maillet AD; Vashisth H; Cote RH
    PLoS One; 2019; 14(3):e0214554. PubMed ID: 30917179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders.
    Bhat A; Ray B; Mahalakshmi AM; Tuladhar S; Nandakumar DN; Srinivasan M; Essa MM; Chidambaram SB; Guillemin GJ; Sakharkar MK
    Pharmacol Res; 2020 Oct; 160():105078. PubMed ID: 32673703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases.
    Omar F; Findlay JE; Carfray G; Allcock RW; Jiang Z; Moore C; Muir AL; Lannoy M; Fertig BA; Mai D; Day JP; Bolger G; Baillie GS; Schwiebert E; Klussmann E; Pyne NJ; Ong ACM; Bowers K; Adam JM; Adams DR; Houslay MD; Henderson DJP
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13320-13329. PubMed ID: 31209056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of phosphodiesterase-4 on ethanol elicited locomotion and narcosis.
    Baliño P; Ledesma JC; Aragon CM
    Neuropharmacology; 2016 Feb; 101():271-8. PubMed ID: 26449868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia induces adenosine release from the rat carotid body.
    Conde SV; Monteiro EC
    J Neurochem; 2004 Jun; 89(5):1148-56. PubMed ID: 15147507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.